Muller TD, Finan B, Bloom SR, D'Alessio D, Drucker DJ, Flatt PR, Fritsche A, Gribble F, Grill HJ, Habener JF, Holst JJ, Langhans W, Meier JJ, Nauck MA, Perez-Tilve D, Pocai A, Reimann F, Sandoval DA, Schwartz TW, Seeley RJ, Stemmer K, Tang-Christensen M, Woods SC, DiMarchi RD, Tschop MH
A medically supervised program can help determine whether treatment is appropriate, monitor progress, answer questions, review side effects, and adjust the plan when needed
A pellet smaller than a grain of rice sits just under the skin and releases hormone steadily for months, so there is no daily pill to remember
That is exciting
Tirzepatide (Mounjaro) (Note: Technically a dual GLP-1/GIP agonist) Approved for diabetes, with weight loss benefits under clinical evaluation for obesity
The diuretic and natriuretic effects of GLP-1 are mediated through downregulation of sodiumhydrogen exchanger 3 (NHE3) activity in the renal proximal tubule that consequently affects renal hemodynamics [112]